Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares rose 6.7% on Monday . The stock traded as high as $1.76 and last traded at $1.76. Approximately 232 shares were traded during trading, a decline of 94% from the average daily volume of 4,182 shares. The stock had previously closed at $1.65.
Mayne Pharma Group Trading Up 6.7%
The firm’s 50-day simple moving average is $1.81 and its two-hundred day simple moving average is $2.47.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Featured Articles
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
